Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [Phase 2]
This update reports the termination of a Phase 2 clinical trial investigating removal of T cells to prevent graft-versus-host disease in bon…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant
This completed clinical trial investigates metabolic syndrome and related cardiovascular and long-term health effects in adolescent and youn…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission [Phase 1, Phase 2]
This completed Phase 1/2 trial from UCSF evaluated a conditioning regimen of busulfan, antithymocyte globulin, and fludarabine followed by d…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease [Phase 1]
Phase 1 trial evaluating donor stem cell transplantation in young patients with congenital amegakaryocytic thrombocytopenia, leukemia, myelo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-11-06Clinical Trial Update: Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
The trial update describes collecting and storing tissue and DNA samples from patients undergoing donor stem cell transplantation, across mu…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant [Phase 2]
Phase 2 trial update evaluating zoledronic acid to prevent osteoporosis in patients undergoing donor stem cell transplantation. The study in…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia [Phase 2]
Phase II study of denileukin diftitox (Ontak) in adult T-cell leukemia was terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [Phase 2]
A Phase 2 clinical trial evaluating donor bone marrow transplantation for various hematologic diseases has completed.
-
CLINICAL_TRIALS withdrawal · 2012-10-11Clinical Trial Update: Infusion of Expanded Cord Blood T Cells [Phase 1]
A Phase 1 clinical trial evaluating the infusion of expanded cord blood T cells for stem cell transplantation in leukemia has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML [Phase 2]
Phase 2 clinical trial evaluating total-body irradiation with fludarabine and alemtuzumab followed by stem cell transplant in patients with …
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Phase 2]
Phase 2 trial evaluating epoetin alfa for treating chemotherapy-induced anemia in cancer patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer [NA]
A clinical trial update reports completion of a donor stem cell transplant study in older or frail patients with hematologic cancers.
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating early administration of anti-thymocyte globulin (ATG) followed by cyclophosphamide, busulfan and fludarabine as a c…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia [Phase 2]
A Phase 2 trial evaluating arsenic trioxide as induction therapy for adult leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) [Phase 2]
A completed Phase II trial of single-agent irinotecan (Camptosar) in leukemia and lymphoma, with correlative laboratory studies.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide [Phase 1, Phase 2]
This document reports the completion of a Phase I/II trial of an induction chemotherapy regimen consisting of daunorubicin, cytarabine, topo…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count [Phase 3]
Phase 3 trial update on preventing infection in patients with hematologic cancers and leukopenia-related fever; the study has been completed…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer [NA]
A clinical trial comparing moxifloxacin with ciprofloxacin plus amoxicillin for fever and neutropenia in cancer patients was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 study of the histone-deacetylase inhibitor JNJ-26481585 in patients with advanced or refractory leukemia or myelodysplastic syndrome…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain [Phase 3]
Phase 3 clinical trial evaluating an opioid titration order sheet versus standard care for cancer-related pain; the study is completed with …
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies [Phase 2]
Phase 2 hematopoietic cell transplantation trial in pediatric patients with hematologic malignancies has completed and results have been pos…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases [Phase 2]
Phase 2 trial assessing megadose CD34+ selected progenitor cell transplantation in patients with advanced hematologic malignancies (leukemia…
-
CLINICAL_TRIALS withdrawal · 2012-08-02Clinical Trial Update: Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets [Phase 3]
This Phase 3 trial comparing fresh random platelets with autologous thrombosol-treated autologous platelets in patients with leukemia or lym…